A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Anhui, China
- Recruiting
- Anhui Provincial Children's Hospital
-
Contact:
- Biquan Chen
- Phone Number: 13856065978
-
Sub-Investigator:
- Biquan Chen
-
Beijing, China
- Recruiting
- Beijing Youan Hospital,Capital Medical University
-
Principal Investigator:
- Xiuhui Li, MD
-
Contact:
- Xiuhui li, MD
- Phone Number: 86-10-93997040
- Email: lixiuhui@sohu.com
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Recruiting
- Guangzhou Women and Children Hospital
-
Contact:
- Yi Xu
- Phone Number: 13416427315
-
Sub-Investigator:
- Yi Xu
-
-
Guangxi
-
Nanning, Guangxi, China
- Recruiting
- The First Affiliated Hospital of Guangxi Medical University
-
Contact:
- Dan Wei
- Phone Number: 13977166581
-
Sub-Investigator:
- Dan Wei
-
-
Henan
-
Kaifeng, Henan, China
- Recruiting
- Kaifeng Municipal Children's Hospital
-
Contact:
- Xi Zhang
- Phone Number: 13069307700
-
Sub-Investigator:
- Xi Zhang
-
-
Hunan
-
Changsha, Hunan, China
- Recruiting
- Hunan Provincial Children's Hospital
-
Contact:
- Shuangjie Li
- Phone Number: 15874162057
-
Sub-Investigator:
- Shuangjie Li
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of severe hand-foot-mouth disease patients according to hand-foot-mouth disease treatment guidelines 2010 issued by China's Ministry of Health
- not more than 24 hours of occurrence of severe symptoms
- age of 1-13 years
- Patients or their guardians agree to participate in this study and signed the informed consent form
Exclusion Criteria:
- Suffering from neurogenic pulmonary edema, heart or lung failure.
- Complicated with other serious diseases such as chronic hepatitis, congenital heart disease, acute or chronic nephritis and blood diseases, etc
- the history of allergies on Chinese medicine
- the history of mild increase of blood bilirubin hemolysis (or uric bravery former positive) phenomenon
- using hormonal therapy
- Attending other clinical studies on hand-foot-mouth disease
- Patients or their guardians suffering from mental illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Western therapy
|
Intervention time: 7-10 days; Follow-up time: 5 days.
|
|
Experimental: Herbal concentrate-granules plus western therapy
|
Intervention time: 7-10 days; Follow-up time: 5 days.
|
|
Experimental: Reduning Injection plus western therapy
|
Intervention time: 7-10 days; Follow-up time: 5 days.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
incidence of complications
Time Frame: 15 days
|
15 days
|
|
incidence of critically ill patients
Time Frame: 15 days
|
15 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
case fatality rate
Time Frame: 15 days
|
15 days
|
|
time of symptom disappearance
Time Frame: 15 days
|
15 days
|
|
time of bringing down a fever
Time Frame: 15 days
|
15 days
|
|
length of stay
Time Frame: 15 days
|
15 days
|
|
dose and usage of hormones
Time Frame: 15 days
|
15 days
|
|
safety outcome(adverse effects)
Time Frame: 15 days
|
15 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 200907001-3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.